Cargando…
The Validation of Multifactor Model of Plasma Aβ(42) and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease
Alzheimer disease (AD) has an insidious onset and heterogeneous clinical symptoms. The well-accepted biomarkers for clinical diagnosis of AD include β-amyloid (Aβ) deposition and pathologic tau level within cerebral spinal fluid (CSF) and imaging AD pathology such as positive emission tomography (PE...
Autores principales: | Jiao, Fubin, Yi, Fang, Wang, Yuanyuan, Zhang, Shouzi, Guo, Yanjun, Du, Wenjin, Gao, Ya, Ren, Jingjing, Zhang, Haifeng, Liu, Lixin, Song, Haifeng, Wang, Luning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385244/ https://www.ncbi.nlm.nih.gov/pubmed/32792940 http://dx.doi.org/10.3389/fnagi.2020.00212 |
Ejemplares similares
-
The Significance of EEG Alpha Oscillation Spectral Power and Beta Oscillation Phase Synchronization for Diagnosing Probable Alzheimer Disease
por: Zhang, Haifeng, et al.
Publicado: (2021) -
Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-old
por: Melikyan, Zarui A., et al.
Publicado: (2021) -
Conversion of MoCA to MMSE scores
por: Falkowski, Jed A., et al.
Publicado: (2015) -
A company experience of the first MoCA pilot project
por: Hughes-Wilson, Wills
Publicado: (2014) -
Comparison of DBFS with MoCA and MMSE tools for MCI screening
por: Chad Chew, Eun Yip, et al.
Publicado: (2023)